Measurements of HRQOL at the time of initial treatment often an independent predictor of overall survival in patients with advanced cancer, but not with early stage cancer.
In a study Medical Outcomes Study Short Form Health Survey in patients treated for head and neck cancer during the first year following diagnosis is a significant predictor of disease specific survival (Jameson).